Olympus (OTCMKTS:OCPNY) Share Price Crosses Below 200-Day Moving Average – Should You Sell?

Olympus Co. (OTCMKTS:OCPNY)’s stock price passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $18.00 and traded as low as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised Olympus to a “buy” rating in a research report on Monday, May 18th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Olympus currently has a consensus rating of “Buy”.

Olympus Trading Down 1.4%

The firm’s fifty day simple moving average is $18.00 and its 200 day simple moving average is $18.00. The stock has a market capitalization of $23.15 billion, a P/E ratio of 21.95, a price-to-earnings-growth ratio of 1.07 and a beta of 0.70. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.48 and a current ratio of 1.99.

Olympus Company Profile

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.